OLD Mission Capital LLC Grows Stock Position in Tilray Inc (NASDAQ:TLRY)

OLD Mission Capital LLC raised its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 23.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 205,164 shares of the company’s stock after acquiring an additional 38,305 shares during the quarter. OLD Mission Capital LLC’s holdings in Tilray were worth $273,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Verdence Capital Advisors LLC purchased a new position in shares of Tilray during the 4th quarter worth approximately $29,000. Dudley Capital Management LLC acquired a new stake in Tilray during the 4th quarter valued at $29,000. Ameritas Advisory Services LLC purchased a new position in Tilray during the fourth quarter worth $32,000. Newman Dignan & Sheerar Inc. raised its holdings in shares of Tilray by 61.9% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock worth $35,000 after acquiring an additional 10,000 shares during the last quarter. Finally, Brooklyn FI LLC purchased a new stake in shares of Tilray in the fourth quarter valued at $36,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Trading Down 2.2 %

Shares of Tilray stock opened at $0.58 on Tuesday. Tilray Inc has a fifty-two week low of $0.54 and a fifty-two week high of $2.77. The business’s fifty day moving average is $0.79 and its two-hundred day moving average is $1.21. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The firm has a market cap of $543.18 million, a PE ratio of -1.93 and a beta of 1.88.

Tilray (NASDAQ:TLRY) last released its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The business had revenue of $210.90 million for the quarter, compared to analysts’ expectations of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company’s revenue was up 8.7% compared to the same quarter last year. Analysts anticipate that Tilray Inc will post -0.2 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group boosted their target price on shares of Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research note on Monday, January 13th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.